ENDRA Life Sciences (NDRA) director Tokman received 9,621 Stock Options
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Alexander Y Tokman (director at ENDRA Life Sciences Inc., NDRA) reported that they received 9,621 Stock Options on Jan 30, 2023.
- Reporting person
- Tokman Alexander Y
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 30, 2023 | Grant or award (A) | Stock OptionsOn 9,621 Common Stock1 | +9,621 | - | - | 9,621 direct |
Holdings before and after
- Stock Options: 0 to 9,621 direct
Footnotes from the filing
- 1. This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Tokman report in this NDRA Form 4?
Alexander Y Tokman (director at ENDRA Life Sciences Inc., NDRA) reported that they received 9,621 Stock Options on Jan 30, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for NDRA
Earlier insider filings at NDRA
- Feb 2, 2023SEC Form 4 filed by Digiandomenico Anthony
- Feb 2, 2023SEC Form 4 filed by Pestrikova Irina
- Feb 2, 2023SEC Form 4 filed by Harsh Michael
- Feb 2, 2023SEC Form 4 filed by Michelon Francois Roger
- Feb 2, 2023SEC Form 4 filed by Thornton Michael Milos
Quantisnow market dataNASDAQ
NDRA
ENDRA Life Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Get push alerts for NDRA
Full NDRA profile on Quantisnow Follow NDRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time